Skip to main content

Monsanto Faces Third Roundup Trial A Day After $80M Verdict

Monsanto Faces Third Roundup Trial A Day After $80M Verdict

Monsanto Faces Third Roundup Trial A Day After $80M Verdict

Introduction

A day after a California jury awarded $80 million to a man suffering from cancer due to Roundup use, an Oakland jury heard opening statements for a married couple's claim filed against Monsanto that the weed killer caused them non-Hodgkin's lymphoma (NHL).

This is the third Roundup trial to go before a jury; it involves claims filed by an elderly couple, who allege that the agro-giant, Monsanto, failed to warn them about the hazards of glyphosate exposure from its popular herbicide. At the start of the trial, the plaintiffs' attorney told a 16-member jury that the couple was using Roundup on their four properties between 1975 and 2011 to kill weeds. They sprayed roughly 1,500 gallons of Roundup and stopped it when the husband came across a commercial, saying it could probably cause cancer. The couple filed their case in 2017 as both were diagnosed with NHL. Wisner told the jurors that he would specify in the closing arguments how the evidence against the company justifies compensatory and punitive damages. The trial's closing arguments are expected by the end of April. An attorney representing Monsanto argued that the couple was suffering from numerous diseases for years and asked the jury to consider the evidence, which says Roundup may not have caused their cancers.

The suit is one of the 11,000 cases filed against Monsanto over allegations that the company hid cancer risk linked to the herbicide, ran a campaign of misinformation to convince government agencies, farmers, and the general public that Roundup was non-hazardous.  

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!